Vance G. Fowler showing at the #ECCMID2019 the promising results of the #phage #lysin #CF301 in S. aureus bacteremia in a phase II trial. The potential for #bacteriophages and #lysins in combination with antibiotics to treat methicillin-resistant staph infections is so exciting!